Atovaquone Suspension
Product Images NDC 17856-8631

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 17856-8631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (17856 8631 01 Rev. 1 Case Label)

Label for Atovaquone oral suspension, USP 750 mg per 5 mL, produced by Atlantic Biologicals Corp. The label includes storage instructions to keep the suspension between 15°-25°C and to shake gently before use. The package contains 50 cups of the suspension. Additional details include a barcode, a QR code, expiration date of 09/30/25, and a note to keep medication out of reach of children.*

FDA Label Image

Atovaquonestructure (Atovaquonestructure)

Chemical structure of the active ingredient Atovaquone, showing its molecular framework with characteristic rings and a chlorine-substituted phenyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.